154 related articles for article (PubMed ID: 23797828)
1. Investigation of the mechanisms governing doxorubicin and irinotecan release from drug-eluting beads: mathematical modeling and experimental verification.
Biondi M; Fusco S; Lewis AL; Netti PA
J Mater Sci Mater Med; 2013 Oct; 24(10):2359-70. PubMed ID: 23797828
[TBL] [Abstract][Full Text] [Related]
2. Chemoembolisation of rat colorectal liver metastases with drug eluting beads loaded with irinotecan or doxorubicin.
Eyol E; Boleij A; Taylor RR; Lewis AL; Berger MR
Clin Exp Metastasis; 2008; 25(3):273-82. PubMed ID: 18259882
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin and irinotecan drug-eluting beads for treatment of glioma: a pilot study in a rat model.
Baltes S; Freund I; Lewis AL; Nolte I; Brinker T
J Mater Sci Mater Med; 2010 Apr; 21(4):1393-402. PubMed ID: 20162337
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a novel intrinsically radiopaque Drug-eluting Bead for image-guided therapy: DC Bead LUMI™.
Ashrafi K; Tang Y; Britton H; Domenge O; Blino D; Bushby AJ; Shuturminska K; den Hartog M; Radaelli A; Negussie AH; Mikhail AS; Woods DL; Krishnasamy V; Levy EB; Wood BJ; Willis SL; Dreher MR; Lewis AL
J Control Release; 2017 Mar; 250():36-47. PubMed ID: 28188808
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of biocompatibility and anti-glioma efficacy of doxorubicin and irinotecan drug-eluting bead suspensions in alginate.
Glage S; Lewis AL; Mertens P; Baltes S; Geigle P; Brinker T
Clin Transl Oncol; 2012 Jan; 14(1):50-9. PubMed ID: 22262719
[TBL] [Abstract][Full Text] [Related]
6. Predicting pharmacokinetic behaviour of drug release from drug-eluting embolization beads using in vitro elution methods.
Hagan A; Caine M; Press C; Macfarlane WM; Phillips G; Lloyd AW; Czuczman P; Kilpatrick H; Bascal Z; Tang Y; Garcia P; Lewis AL
Eur J Pharm Sci; 2019 Aug; 136():104943. PubMed ID: 31152772
[TBL] [Abstract][Full Text] [Related]
7. Transarterial hepatic chemoembolization with 70-150 µm drug-eluting beads: assessment of clinical safety and liver toxicity profile.
Odisio BC; Ashton A; Yan Y; Wei W; Kaseb A; Wallace MJ; Vauthey JN; Gupta S; Tam AL
J Vasc Interv Radiol; 2015 Jul; 26(7):965-71. PubMed ID: 25979305
[TBL] [Abstract][Full Text] [Related]
8. Development of a combination drug-eluting bead: towards enhanced efficacy for locoregional tumour therapies.
Forster RE; Tang Y; Bowyer C; Lloyd AW; Macfarlane W; Phillips GJ; Lewis AL
Anticancer Drugs; 2012 Apr; 23(4):355-69. PubMed ID: 22241169
[TBL] [Abstract][Full Text] [Related]
9. Preservation of the active lactone form of irinotecan using drug eluting beads for the treatment of colorectal cancer metastases.
Tang Y; Czuczman PR; Chung ST; Lewis AL
J Control Release; 2008 Apr; 127(1):70-8. PubMed ID: 18237814
[TBL] [Abstract][Full Text] [Related]
10. Stability of irinotecan-loaded drug eluting beads (DC Bead) used for transarterial chemoembolization.
Kaiser J; Thiesen J; Krämer I
J Oncol Pharm Pract; 2010 Mar; 16(1):53-61. PubMed ID: 19617306
[TBL] [Abstract][Full Text] [Related]
11. Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties.
Taylor RR; Tang Y; Gonzalez MV; Stratford PW; Lewis AL
Eur J Pharm Sci; 2007 Jan; 30(1):7-14. PubMed ID: 17030118
[TBL] [Abstract][Full Text] [Related]
12. Chemoembolization with drug eluting beads preloaded with irinotecan (DEBIRI) vs doxorubicin (DEBDOX) as a second line treatment for liver metastases from cholangiocarcinoma: a preliminary study.
Venturini M; Sallemi C; Agostini G; Marra P; Cereda S; Reni M; Aldrighetti L; De Cobelli F; Del Maschio A
Br J Radiol; 2016 Nov; 89(1067):20160247. PubMed ID: 27558984
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin and mitoxantrone drug eluting beads for the treatment of experimental peritoneal carcinomatosis in colorectal cancer.
Keese M; Gasimova L; Schwenke K; Yagublu V; Shang E; Faissner R; Lewis A; Samel S; Löhr M
Int J Cancer; 2009 Jun; 124(11):2701-8. PubMed ID: 19165866
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of ion exchange processes in drug-eluting embolization beads by use of an improved flow-through elution method.
Swaine T; Tang Y; Garcia P; John J; Waters LJ; Lewis AL
Eur J Pharm Sci; 2016 Oct; 93():351-9. PubMed ID: 27523788
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of novel formulations for transarterial chemoembolization: combining elements of Lipiodol emulsions with Drug-eluting Beads.
Caine M; Chung T; Kilpatrick H; Bascal Z; Willis S; Tang Y; de Baere T; Dreher M; Lewis A
Theranostics; 2019; 9(19):5626-5641. PubMed ID: 31534507
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of chemoembolization loadable beads: in vitro drug release and physical properties of DC bead and hepasphere loaded with doxorubicin and irinotecan.
Jordan O; Denys A; De Baere T; Boulens N; Doelker E
J Vasc Interv Radiol; 2010 Jul; 21(7):1084-90. PubMed ID: 20610183
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin eluting beads-2: methods for evaluating drug elution and in-vitro:in-vivo correlation.
Gonzalez MV; Tang Y; Phillips GJ; Lloyd AW; Hall B; Stratford PW; Lewis AL
J Mater Sci Mater Med; 2008 Feb; 19(2):767-75. PubMed ID: 17653626
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary artery chemoembolization in a sheep model: Evaluation of performance and safety of irinotecan eluting beads (DEB-IRI).
Baylatry MT; Pelage JP; Wassef M; Ghegediban H; Joly AC; Lewis A; Lacombe P; Fernandez C; Laurent A
J Biomed Mater Res B Appl Biomater; 2011 Aug; 98(2):351-9. PubMed ID: 21656666
[TBL] [Abstract][Full Text] [Related]
19. Treatment of experimental pancreatic cancer by doxorubicin-, mitoxantrone-, and irinotecan-drug eluting beads.
Yagublu V; Caliskan N; Lewis AL; Jesenofsky R; Gasimova L; Löhr JM; Keese M
Pancreatology; 2013; 13(1):79-87. PubMed ID: 23395574
[TBL] [Abstract][Full Text] [Related]
20. Comparison of DC Bead-irinotecan and DC Bead-topotecan drug eluting beads for use in locoregional drug delivery to treat pancreatic cancer.
Forster RE; Small SA; Tang Y; Heaysman CL; Lloyd AW; Macfarlane W; Phillips GJ; Antonijevic MD; Lewis AL
J Mater Sci Mater Med; 2010 Sep; 21(9):2683-90. PubMed ID: 20563626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
